Table of contents for New trends in cancer for the 21st century / edited by Antonio Llombart-Bosch, Vincente Felipo, and José Antonio López-Guerrero.


Bibliographic record and links to related information available from the Library of Congress catalog
Note: Electronic data is machine generated. May be incomplete or contain other coding.


Counter
P reface .......................... ........ ............. ...................................................... xi
List of  Contributors ............................................U........................................... xvi
1. Prognostic and Therapeutic Targets in the Ewing's Family
of  Tum ors (PROTH ETS). .... .... ..... .. .............. ..... ..  .............................
"P. Pici, K. Scotlandi, M. Serra, and A. Rizzi
2. Targeted Therapies in Ewing's Sarcoma .......  ...... ............................. 13
K. Scotlandi
3. The CCN3 Protein  and  Cancer ................ .. .... .. . . ... ...........23
B. Perbal
4. Ews-Flil in Ewing's Sarcoma: Real Targets
and  C ollateral D am age  ....................... .. ....... ........ .................... .. ...1.......
SBan, C. Siligan, M. Kreppel, D. Aryee, and H. Kovar
5. Molecular Karyotyping in Sarcoma Diagnostics and Research..............53
H. Vauhkonen, S. Savola, S. Kaur, M.L. Larramendy,
and S. Knuutila
6. TuBaFrost: European Virtual Tumor Tissue Banking ......................... 65
P.H.J. Riegman, M.H.A. Oomen, WN.M. Dinjens, J.W    Oosterhuis,
K.H. Lam, A. Spatz, C. Ratcliffe, K. Knox, R. Mager,
vii
D. Kerr, E Pezzella. B. van Damme, M. van de Vijver,
H. van Boven, M.M. Morente, S. Alonso, D. Kerjaschki,
J. Pammer, J.A. Lopez-Guerrero, A. Llombart-Bosch,
A. Carbone, A. Gloghini, I. Teodorovic, M. Isabelle,
A. Passioukov, S. Lejeune, P. Therasse, and E.-B. van Veen
7. Virtual Microscopy in Virtual Tumor Banking...._.............. ................... 75
M. Isabelle, I. Teodorovic, J.W Oosterhuis, PH.J. Riegman,
and the TuBaFrost Consortium
8. Harmonizing Cancer Control in  Europe  ................................ ..........   87
U. Ringborg
9. The Diagnosis of Cancer: "From H&E to Molecular
D iagnosis  and  B ack"  .. .................... .... .......... .. ..... ............ . .. .. .............   95
J. Costa
10. From Morphological to Molecular Diagnosis of Soft Tissue Tumors. .... 99
M. Miettinen
11. Prediction of Response to Neoadjuvant Chemotherapy
in Carcinomas of the Upper Gastrointestinal Tract ... ................ 115
H. H6fler, R. Langer, K. Ott, and G. Keller
12. Integrating the Diagnosis of Childhood Malignancies ... .. ..........................121
D. L6pez-Terrada
13. Preclinical Models for Cell Cycle-Targeted Therapies .................. 139
M. Malumbres
14. WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer .......49
D. Ramos, and C.M, Aldaz
15. From Genome to Proteome in Tumor Profiling: Molecular
Events in  Colorectal Cancer Genesis .........  .......... . .......... .................. ....  161
J.K. Habermann, U.J. Roblick, M. Upender, T. Ried,
and G. Auer
16. Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma
and  Breast Cancer M odels ........ ................  .... . .. .... .... ........ ............ 179
L. Holmquist, T. L6fstedt, and S. PAhiman
17. Methylation Patterns and Chemosensitivity in NSCLC ....... ..... .... 195
J.L. Ramirez, M.F. Salazar, J. Gupta, J.M. Sanchez, M. Taron,
M. Sanchez-Ronco, Vicente Alberola, and R. de las Pefias
18. Pharmacogenomics and Colorectal Cancer ......... ....... ............ ...........11
H.J. Lenz
19. Development of Pharmacogenomic Predictors for Preoperative
Chemotherapy of Breast Cancer ................... ..... ...33
L. Pusztai
20. Vascular Endothelial Growth Factor Inhibitors
in  C olon  C ancer  ........... .. ................  ........ .... .............25
E. Diaz-Rubio
21. Molecular Imaging of Cancer Using PET and SPECT ........ .............277
A. Kjar
22. MRS as Endogenous Molecular Imaging for Brain
and Prostate Tumors: FP6 Project "eTUMOR" ................................285
B. Celda, D. Monle6n, M.C. Martinez-Bisbal, V Esteve,
B. Martinez-Granados. E. Pifiero, R. Ferrer, JI Piquer,
L. Marti-Bonmati, and J. Cervera
23. From Linac to Tomotherapy: New Possibilities for Cure? .......................303
G. Storme, D. Verellen, G. Soete, N. Linthout, J. Van de Steene,
M. Voordeckers, V Vinh-Hung, K. Tournel, and D. Van den Berge
24. Targeting mTOR for Cancer Treatment..... ........................ .......  ... 309
B. Rubio-Viqueira, and M. Hidalgo
25. Dual/Pan-Her Tyrosine Kinase Inhibitors: Focus
in  Breast Cancer ............................ ......... .. ........ . .   329
J. Albanell
26. AntiTumor-Associated Antigens IGGS: Dual Positive
and Negative Potential Effects for Cancer Therapy .............................34
E. Barbera Guillem, and JW Sampsel
27. Synergistic Molecular Mechanisms in Hormone-Sensitive
Breast Cancer  ...... . ........ ....... ......... .. ........................ 375
A. Llorbart Cussac



Library of Congress subject headings for this publication: Cancer Treatment Congresses, Cancer Molecular aspects Congresses